Skip to main content
57°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Johnson & Johnson
< Previous
1
2
3
Next >
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
April 25, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow
April 24, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Dividend Increase of 5.3%
April 18, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Reports Q1 2023 Results
April 18, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Subsidiary LTL Management LLC (“LTL”) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims
April 04, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 15, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
March 15, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.
March 08, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
February 14, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference
February 14, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
February 13, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
February 02, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
January 24, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
January 18, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2023
January 03, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Completes Acquisition of Abiomed
December 22, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
December 14, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
December 13, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 07, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
November 30, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Abiomed
November 01, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
ABMD
JNJ
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2022
October 19, 2022
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Reports Q3 2022 Results
October 18, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
October 03, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
September 28, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
September 20, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces $5 Billion Share Repurchase Program
September 14, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 13, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
August 24, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
August 09, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.